KYTX
Price
$8.33
Change
+$1.27 (+17.99%)
Updated
Feb 3 closing price
Capitalization
497.12M
56 days until earnings call
Intraday BUY SELL Signals
VTGN
Price
$0.54
Change
-$3.67 (-87.17%)
Updated
Feb 3 closing price
Capitalization
21.69M
Intraday BUY SELL Signals
Interact to see
Advertisement

KYTX vs VTGN

Header iconKYTX vs VTGN Comparison
Open Charts KYTX vs VTGNBanner chart's image
Kyverna Therapeutics
Price$8.33
Change+$1.27 (+17.99%)
Volume$658.57K
Capitalization497.12M
VistaGen Therapeutics
Price$0.54
Change-$3.67 (-87.17%)
Volume$1.1M
Capitalization21.69M
KYTX vs VTGN Comparison Chart in %
KYTX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KYTX vs. VTGN commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYTX is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (KYTX: $8.33 vs. VTGN: $0.54)
Brand notoriety: KYTX and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYTX: 36% vs. VTGN: 31%
Market capitalization -- KYTX: $497.12M vs. VTGN: $21.69M
KYTX [@Biotechnology] is valued at $497.12M. VTGN’s [@Biotechnology] market capitalization is $21.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYTX’s FA Score shows that 0 FA rating(s) are green whileVTGN’s FA Score has 1 green FA rating(s).

  • KYTX’s FA Score: 0 green, 5 red.
  • VTGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYTX and VTGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYTX’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 4 bullish TA indicator(s).

  • KYTX’s TA Score: 3 bullish, 5 bearish.
  • VTGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than KYTX.

Price Growth

KYTX (@Biotechnology) experienced а -10.24% price change this week, while VTGN (@Biotechnology) price change was -10.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.22%. For the same industry, the average monthly price growth was +3.03%, and the average quarterly price growth was +35.17%.

Reported Earning Dates

KYTX is expected to report earnings on Apr 01, 2026.

Industries' Descriptions

@Biotechnology (-4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYTX($497M) has a higher market cap than VTGN($21.7M). KYTX YTD gains are higher at: -11.383 vs. VTGN (-17.873). VTGN has higher annual earnings (EBITDA): -64.79M vs. KYTX (-158.93M). KYTX has more cash in the bank: 171M vs. VTGN (77.2M). VTGN has less debt than KYTX: VTGN (1.87M) vs KYTX (5.02M). VTGN has higher revenues than KYTX: VTGN (721K) vs KYTX (0).
KYTXVTGNKYTX / VTGN
Capitalization497M21.7M2,290%
EBITDA-158.93M-64.79M245%
Gain YTD-11.383-17.87364%
P/E RatioN/AN/A-
Revenue0721K-
Total Cash171M77.2M222%
Total Debt5.02M1.87M269%
FUNDAMENTALS RATINGS
VTGN: Fundamental Ratings
VTGN
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYTXVTGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
88%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KYTX
Daily Signal:
Gain/Loss:
VTGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEN64.050.05
+0.08%
New England Realty Associates Limited
IOBT0.28N/A
-0.58%
IO Biotech
OCSL12.14-0.10
-0.82%
Oaktree Specialty Lending Corp
MRVL75.54-3.12
-3.97%
Marvell Technology
KD22.21-1.10
-4.72%
Kyndryl Holdings

KYTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYTX has been loosely correlated with VTGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KYTX jumps, then VTGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYTX
1D Price
Change %
KYTX100%
N/A
VTGN - KYTX
43%
Loosely correlated
-6.19%
CLYM - KYTX
42%
Loosely correlated
+8.88%
RXRX - KYTX
42%
Loosely correlated
-1.91%
IMNM - KYTX
41%
Loosely correlated
+3.18%
FDMT - KYTX
41%
Loosely correlated
+3.72%
More

VTGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with TRAW. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-6.19%
TRAW - VTGN
42%
Loosely correlated
N/A
IMNM - VTGN
42%
Loosely correlated
+3.18%
IPSC - VTGN
39%
Loosely correlated
N/A
SYRE - VTGN
38%
Loosely correlated
+1.65%
REPL - VTGN
38%
Loosely correlated
+5.81%
More